Pathophysiology of itching

Lancet

Volumn 348, Issue 9032, 1996, Pages 938-940

  Greaves, M W ^a   Wall, P D ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HISTAMINE; INTERLEUKIN 2; MU OPIATE RECEPTOR; SUBSTANCE P; TACHYKININ;

CENTRAL NERVOUS SYSTEM; HISTAMINE RELEASE; MAST CELL; PAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PRURITUS; SCRATCHING; SHORT SURVEY; SKIN DISEASE; SYMPTOM; URTICARIA;

EID: 0030571196     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)04328-0     Document Type: Review

References (30)

1. 1 Hebra FV. On diseases of the skin London: New Sydenham Society Translation, 1868, Vol 2 p 257.
2. 2 Lewis T, Grant RT, Marvin HM. Vascular reaction of skin to injury. Part X: The intervention of a chemical stimulus illustrated especially by flare. The response to Faradism. Heart 1927; 14: 139-60.
3. 2-receptor blocking agent. Br J Clin Pharmacol 1977; 4: 367-69.
4. 4 Robertson I, Greaves MW. Responses of human skin blood vessels to synthetic histamine analogues. Br J Clin Pharmacol 1978; 5: 319-22.
5. 5 Davies MG, Greaves MW. Sensory responses of human skin to synthetic histamine analogues and histamine. Br J Clin Pharmacol 1980; 9: 461-65.
6. 3 receptors. Nature 1987; 327: 117-23.
7. 7 Brandes LJ, LaBella FS. Identification of intracellular histamine receptors (Hic) that regulate cell proliferation. Adv Biosci 1993; 89: 31-41.
8. 8 Cook J, Shuster S. Histamine weal formation and absorption in man. Br J Pharmacol 1980; 69: 579-85.
9. 9 Hide M, Francis DM, Grattan CEH, Hakimi J, Kochan JP, Greaves MW. Auto antibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328: 1599-604.
10. 10 Fiebiger E, Maurer D, Holub H, et al. Serum IgG autoantibodies directed against the α-chain of FC∈RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients? J Clin Invest 1995; 96: 2606-12.
11. 11 Krause L, Shuster S. Mechanism of action of antipruritic drugs. BMJ 1983; 287: 1199-200.
12. 2 alpha in epidermis of psoriasis. Proc Natl Acad Sci USA 1975; 72: 5130-34.
13. 13 Greaves MW, Sondergaard J, McDonald Gibson W. Recovery of prostaglandins from human cutaneous inflammation. BMJ 1971; ii: 258-60.
14. 14 Black AK, Barr RM, Wong E, et al. Lipoxygenase products of arachidonic acid in human inflamed skin. Br J Clin Pharmacol 1985; 20: 185-90.
15. 15 Greaves MW, McDonald Gibson W. Itch: the role of prostaglandins. BMJ 1973; ii: 608-09.
16. 16 Jorizzo JL, Coutts AA, Eady RA, Greaves MW. Vascular responses of human skin to injection of substance P and mechanism of action. Eur J Pharmacol 1983; 87: 67-76.
17. 17 Church MK, El-Lati, Suhad Caulfull JP. Neuropeptide-induced secretion from human skin mast cells. Int Arch Allergy Appl Immunol 1991; 94: 310-18.
18. 18 Lynn B, Capsaicin: actions on C fibre afferents that may be involved in itch. Skin Pharmacol 1992; 5: 9-13.
19. 19 Breneman DL, Cardone JS, Blumsack RF, Lather RM, Searle EA, Pollack VE. Topical capsaicin for treatment of haemodialysis-related pruritus. J Am Acad Dermatol 1992; 26: 91-94.
20. 20 Wallengren J. Treatment of notalgia paresthetica with topical capsaicin. J Am Acad Dermatol 1991; 24: 286-88.
21. 21 Hagermark O, Fjellner B. Enhancement of histamine induced pruritus by enkephalin and morphine. J Invest Dermatol 1980; 74: 459 (abstr).
22. 22 Jones EA, Bergasa NV. The pruritus of cholestasis and the opioid system. JAMA 1992; 268: 3359-62.
23. 23 Schworer H, Ramadori G. Improvement of cholestatic pruritus with odansetron. Lancet 1993; 341: 1277.
24. 24 Dowd PM, Camp RDR, Greaves MW. Human recombinant interleukin-1 alpha is proinflammatory in normal human skin. Skin Pharmacol 1988; 1: 30-37.
25. 25 Gaspari AA, Lotze MT, Rosenberg SA, Stern JB, Katz SI. Dermatologic changes associated with interleukin-2 administration. JAMA 1987; 258: 1624-29.
26. 26 Wahlgren CF, Tengval L, Linder H, Hagermark O, Scheynius A. Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects. Arch Dermatol Res 1995; 287: 572-80.
27. 27 Wahlgren CF, Scheynius A, Hagermark O. Antipruritic effect of oral cyclosporin A in atopic dermatitis. Acta Derm Venereol (Stockh) 1990; 70: 323-29.
28. 28 Tsai JC, Feingold KR, Crumrine D, Wood LC, Grunfeld C, Elias PM. Permeability barrier disruption alters the localisation and expression of TNFα/protein in the epidermis. Arch Dermatol Res 1994; 286: 242-48.
29. 29 Greaves MW, Black AK, Eady RAJ. Aquagenic pruritus. BMJ 1981; 282: 2008-10.
30. 30 Wall PD, Melzack R, eds. Textbook of pain, 3rd edition. Churchill Livingstone: Edinburgh, London; 1995.